Table of Contents Author Guidelines Submit a Manuscript
Journal of Analytical Methods in Chemistry
Volume 2017, Article ID 1073607, 13 pages
https://doi.org/10.1155/2017/1073607
Research Article

Metabolite Profiling, Pharmacokinetics, and In Vitro Glucuronidation of Icaritin in Rats by Ultra-Performance Liquid Chromatography Coupled with Mass Spectrometry

Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China

Correspondence should be addressed to Shuzhang Du; moc.361@119gnahzuhsud and Xiaojian Zhang; moc.361@bxy_naijoaixgnahz

Received 5 April 2017; Accepted 23 May 2017; Published 10 July 2017

Academic Editor: Filomena Conforti

Copyright © 2017 Beibei Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Editorial Committee of Pharmacopoeia of Ministry of Health PR China, The Pharmacopeoia of People's Republic of China (Part 1), Chemical Industry Press, Beijing, China, 2015.
  2. H. Ma, X. He, Y. Yang, M. Li, D. Hao, and Z. Jia, “The genus Epimedium: an ethnopharmacological and phytochemical review,” Journal of Ethnopharmacology, vol. 134, no. 3, pp. 519–541, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. F. Xu, Y. Ding, Y. Guo et al., “Anti-osteoporosis effect of Epimedium via an estrogen-like mechanism based on a system-level approach,” Journal of Ethnopharmacology, vol. 177, pp. 148–160, 2016. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Zhou, J. Wu, X. Chen et al., “Icariin and its derivative, ICT, exert anti-inflammatory, anti-tumor effects, and modulate myeloid derived suppressive cells (MDSCs) functions,” International Immunopharmacology, vol. 11, no. 7, pp. 890–898, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. S.-H. Chen, M. Lei, X.-H. Xie et al., “PLGA/TCP composite scaffold incorporating bioactive phytomolecule icaritin for enhancement of bone defect repair in rabbits,” Acta Biomaterialia, vol. 9, no. 5, pp. 6711–6722, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. X. Lai, Y. Ye, C. Sun et al., “Icaritin exhibits anti-inflammatory effects in the mouse peritoneal macrophages and peritonitis model,” International Immunopharmacology, vol. 16, no. 1, pp. 41–49, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Peng, G. Zhang, B.-T. Zhang et al., “The beneficial effect of Icaritin on osteoporotic bone is dependent on the treatment initiation timing in adult ovariectomized rats,” Bone, vol. 55, no. 1, pp. 230–240, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. S. W. Lei, G. Cui, G. P. H. Leung et al., “Icaritin protects against oxidative stress-induced injury in cardiac H9c2 cells via Akt/Nrf2/HO-1 and calcium signalling pathways,” Journal of Functional Foods, vol. 18, pp. 213–223, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Li, P. Liu, R. Zhang et al., “Icaritin induces cell death in activated hepatic stellate cells through mitochondrial activated apoptosis and ameliorates the development of liver fibrosis in rats,” Journal of Ethnopharmacology, vol. 137, no. 1, pp. 714–723, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. F. Sun, I. R. Indran, Z. W. Zhang et al., “A novel prostate cancer therapeutic strategy using icaritin-activated arylhydrocarbon-receptor to co-target androgen receptor and its splice variants,” Carcinogenesis, vol. 36, no. 7, pp. 757–768, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. M.-C. Jiang, X.-H. Chen, X. Zhao, X.-J. Zhang, and W.-F. Chen, “Involvement of IGF-1 receptor signaling pathway in the neuroprotective effects of Icaritin against MPP+-induced toxicity in MES23.5 cells,” European Journal of Pharmacology, vol. 786, pp. 53–59, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Liao, Y. Liu, H. Wu et al., “The role of icaritin in regulating Foxp3/IL17a balance in systemic lupus erythematosus and its effects on the treatment of MRL/lpr mice,” Clinical Immunology, vol. 162, pp. 74–83, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Chen, Y. H. Zhao, X. B. Jia, and M. Hu, “Intestinal absorption mechanisms of prenylated flavonoids present in the heat-processed Epimedium koreanum Nakai (Yin Yanghuo),” Pharmaceutical Research, vol. 25, no. 9, pp. 2190–2199, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Zhou, Y. H. Ma, Z. Zhou, Y. Chen, Y. Wang, and X. Gao, “Special section on drug metabolism and the microbiome intestinal absorption and metabolism of epimedium flavonoids in osteoporosis rats,” Drug Metabolism and Disposition, vol. 43, no. 10, pp. 1590–1600, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. Y.-T. Wu, C.-W. Lin, L.-C. Lin, A. W. Chiu, K.-K. Chen, and T.-H. Tsai, “Analysis of biliary excretion of icariin in rats,” Journal of Agricultural and Food Chemistry, vol. 58, no. 18, pp. 9905–9911, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Zhao, M. Fan, L. Fan, J. Sun, and D. Guo, “Liquid chromatography-tandem mass spectrometry analysis of metabolites in rats after administration of prenylflavonoids from Epimediums,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 878, no. 15-16, pp. 1113–1124, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. Q. Chang, G.-N. Wang, Y. Li, L. Zhang, C. You, and Y. Zheng, “Oral absorption and excretion of icaritin, an aglycone and also active metabolite of prenylflavonoids from the Chinese medicine Herba Epimedii in rats,” Phytomedicine, vol. 19, no. 11, pp. 1024–1028, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. Q. Qian, S.-L. Li, E. Sun et al., “Metabolite profiles of icariin in rat plasma by ultra-fast liquid chromatography coupled to triple-quadrupole/time-of-flight mass spectrometry,” Journal of Pharmaceutical and Biomedical Analysis, vol. 66, pp. 392–398, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Jin, C.-S. Wu, J.-L. Zhang, and Y.-F. Li, “A new strategy for the discovery of epimedium metabolites using high-performance liquid chromatography with high resolution mass spectrometry,” Analytica Chimica Acta, vol. 768, no. 1, pp. 111–117, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Cui, F. Xu, J. Jiang et al., “Identification of metabolites of epimedin A in rats using UPLC/Q-TOF-MS,” Chromatographia, vol. 77, no. 17-18, pp. 1223–1234, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Liu, H. Sun, D. Lu et al., “Identification of glucuronidation and biliary excretion as the main mechanisms for gossypol clearance: in vivo and in vitro evidence,” Xenobiotica, vol. 44, no. 8, pp. 696–707, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. F. Li, Y. Tan, H. Chen et al., “Identification of schisandrin as a vascular endothelium protective component in YiQiFuMai powder injection using HUVECs binding and HPLC-DAD-Q-TOF-MS/MS analysis,” Journal of Pharmacological Sciences, vol. 129, no. 1, pp. 1–8, 2015. View at Publisher · View at Google Scholar
  23. D. Lu, Z. Ma, T. Zhang, X. Zhang, and B. Wu, “Metabolism of the anthelmintic drug niclosamide by cytochrome P450 enzymes and UDP-glucuronosyltransferases: metabolite elucidation and main contributions from CYP1A2 and UGT1A1,” Xenobiotica, vol. 46, no. 1, pp. 1–13, 2016. View at Publisher · View at Google Scholar · View at Scopus
  24. J. M. Hutzler and T. S. Tracy, “Atypical kinetic profiles in drug metabolism reactions,” Drug Metabolism and Disposition, vol. 30, no. 4, pp. 355–362, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. US FDA, Guidance for Industry: Bioanalytical Method Validation, US Department of Health and Human Services, Center for Drug Evaluation and Research (CDER), http://www.fda.gov/cder/guidance, 2001.
  26. B. K. Matuszewski, M. L. Constanzer, and C. M. Chavez-Eng, “Matrix effect in quantitative LCMSMS analyses of biological fluids: a method for determination of finasteride in human plasma at picogram per milliliter concentrations,” Analytical Chemistry, vol. 70, no. 5, pp. 882–889, 1998. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Troberg, E. Järvinen, G. Ge, L. Yang, and M. Finel, “UGT1A10 Is a high activity and important extrahepatic enzyme: why has its role in intestinal glucuronidation been frequently underestimated?” Molecular Pharmaceutics, Ahead of Print, 2016. View at Publisher · View at Google Scholar
  28. D. Lu, H. Liu, W. Ye, Y. Wang, and B. Wu, “Structure- and isoform-specific glucuronidation of six curcumin analogs,” Xenobiotica, pp. 1–10, 2016. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Sun, H. Wang, H. Liu, X. Zhang, and B. Wu, “Glucuronidation of capsaicin by liver microsomes and expressed UGT enzymes: reaction kinetics, contribution of individual enzymes and marked species differences,” Expert Opinion on Drug Metabolism and Toxicology, vol. 10, no. 10, pp. 1325–1336, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. X. Wang, “Studies on serum pharmacochemistry of traditional Chiese medicine,” World Science And Technology/Modernization of Traditional Chinese Medicine, vol. 4, no. 2, pp. 1–4, 2002. View at Google Scholar
  31. R. Zhang, S. Gilbert, X. Yao et al., “Natural compound methyl protodioscin protects against intestinal inflammation through modulation of intestinal immune responses,” Pharmacology Research Perspectives, vol. 3, article e00118, no. 2, 2015. View at Publisher · View at Google Scholar
  32. B. Wu, K. Kulkarni, S. Basu, S. Zhang, and M. Hu, “First-pass metabolism via UDP-glucuronosyltransferase: a barrier to oral bioavailability of phenolics,” Journal of Pharmaceutical Sciences, vol. 100, no. 9, pp. 3655–3681, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. B. Wu, D. Dong, M. Hu, and S. Zhang, “Quantitative prediction of glucuronidation in humans using the in vitro-in vivo extrapolation approach,” Current Topics in Medicinal Chemistry, vol. 13, no. 11, pp. 1343–1352, 2013. View at Publisher · View at Google Scholar · View at Scopus